Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Clinical and Experimental Medicine
|
June 30, 2025
Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer
Giulia Chisari, Emanuele Martorana, Sofia Paola Lombardo, et al.
Leukemia Research
|
November 5, 2013
CD200 expression in patients with Multiple Myeloma: another piece of the puzzle
Concetta Conticello, Raffaella Giuffrida, Nunziatina Parrinello, et al.
Cells
|
August 9, 2024
A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia
Emanuele Martorana, Gabriele Raciti, Raffaella Giuffrida, et al.
Acta Haematologica
|
August 22, 2008
Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia
Concetta Conticello, Luana Adamo, Luisa Vicari, et al.
Frontiers in Oncology
|
June 1, 2022
<i>Ex Vivo</i> Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction <i>In Vivo</i>
Caterina Puglisi, Raffaella Giuffrida, Giuseppina Borzì, et al.
Journal of Translational Medicine
|
November 4, 2023
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance
Simona D'Aprile, Simona Denaro, Anna Maria Pavone, et al.
International Journal of Cancer
|
February 11, 2012
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Concetta Conticello, Daniela Martinetti, Luana Adamo, et al.
Leukemia Research
|
August 3, 2010
NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
Concetta Conticello, Raffaella Giuffrida, Luana Adamo, et al.
Cancers
|
June 22, 2023
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC)
Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza, et al.
Cancers
|
March 28, 2024
Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). <i>Cancers</i> 2023, <i>15</i>, 2796
Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Clinical and Experimental Medicine
|
June 30, 2025
Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer
Giulia Chisari, Emanuele Martorana, Sofia Paola Lombardo, et al.
Leukemia Research
|
November 5, 2013
CD200 expression in patients with Multiple Myeloma: another piece of the puzzle
Concetta Conticello, Raffaella Giuffrida, Nunziatina Parrinello, et al.
Cells
|
August 9, 2024
A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia
Emanuele Martorana, Gabriele Raciti, Raffaella Giuffrida, et al.
Acta Haematologica
|
August 22, 2008
Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia
Concetta Conticello, Luana Adamo, Luisa Vicari, et al.
Frontiers in Oncology
|
June 1, 2022
<i>Ex Vivo</i> Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction <i>In Vivo</i>
Caterina Puglisi, Raffaella Giuffrida, Giuseppina Borzì, et al.
Journal of Translational Medicine
|
November 4, 2023
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance
Simona D'Aprile, Simona Denaro, Anna Maria Pavone, et al.
International Journal of Cancer
|
February 11, 2012
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Concetta Conticello, Daniela Martinetti, Luana Adamo, et al.
Leukemia Research
|
August 3, 2010
NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
Concetta Conticello, Raffaella Giuffrida, Luana Adamo, et al.
Cancers
|
June 22, 2023
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC)
Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza, et al.
Cancers
|
March 28, 2024
Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). <i>Cancers</i> 2023, <i>15</i>, 2796
Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza, et al.
Page
of 4